Protagonist Therapeutics Inc. (PTGX)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XMEX $
140. 91
+8.89
+6.7338%
$
8.44B Market Cap
- P/E Ratio
- Div Yield
519,100 Volume
0.75 Eps
$ 132.02
Previous Close 
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.11 | - |
| | | 0.25 | 1.98 |
| | | - | - |
| | | - | - |
| | | 1.19 | 3.26 |
| | | 1.19 | - |
| | | - | 0.44 |
| | | - | - |
| | | - | - |
| | | - | - |
PTGX Earnings Reports FAQ
What is the earnings per share (EPS) for PTGX?
The current EPS is 0.75.
What is the company's earnings growth rate?
Protagonist Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Protagonist Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Protagonist Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PTGX at this time, as Protagonist Therapeutics Inc has no recent EPS data to calculate it.
